STOCK TITAN

Tandem Diabetes (TNDM) EVP reports RSU exercises, tax share withholding and trust holdings

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tandem Diabetes Care executive Elizabeth Anne Gasser reported several compensation-related stock transactions dated May 15, 2026. She exercised restricted stock units into a total of 10,267 shares of common stock at a stated price of $0.00 per share and received a separate grant of 1,337 shares at $10.90 per share.

To cover tax obligations on these vestings, the company withheld 5,510 shares at $12.82 per share, and the footnotes state that no shares were sold. After these transactions, she directly holds 1,762 shares of common stock and indirectly holds 25,949 shares through The Gasser Family Trust. A footnote also notes voluntary reporting of an acquisition under the company’s Employee Stock Purchase Plan for a period ending May 15, 2026.

Positive

  • None.

Negative

  • None.
Insider Gasser Elizabeth Anne
Role EVP, Chief Strategy Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 1,503 $0.00 --
Exercise Restricted Stock Unit 1,097 $0.00 --
Exercise Restricted Stock Unit 7,667 $0.00 --
Exercise Common Stock 1,503 $0.00 --
Tax Withholding Common Stock 807 $12.82 $10K
Exercise Common Stock 1,097 $0.00 --
Tax Withholding Common Stock 589 $12.82 $8K
Exercise Common Stock 7,667 $0.00 --
Tax Withholding Common Stock 4,114 $12.82 $53K
Grant/Award Common Stock 1,337 $10.90 $15K
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct); Common Stock — 2,569 shares (Direct); Common Stock — 25,949 shares (Indirect, See Footnote)
Footnotes (1)
  1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c). The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee. Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 23, 2024 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 30, 2025 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
RSU exercises 10,267 shares Common stock from RSU exercises on May 15, 2026
New share grant 1,337 shares at $10.90 Common stock grant on May 15, 2026
Tax withholding shares 5,510 shares at $12.82 Shares withheld for tax on RSU vesting
Direct holdings after transactions 1,762 shares Tandem Diabetes common stock directly held post-transaction
Indirect trust holdings 25,949 shares Held by The Gasser Family Trust
ESPP purchase period Nov 18, 2025–May 15, 2026 Employee Stock Purchase Plan period referenced in footnote
Restricted Stock Unit financial
"The filing lists several transactions involving "Restricted Stock Unit" with underlying common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Purchase Plan financial
"A footnote references the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP)."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(c) regulatory
"The ESPP acquisition is described as a transaction exempt under Rule 16b-3(c)."
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
Long-Term Incentive Plan financial
"Footnotes state certain RSU awards were granted under the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan."
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
tax withholding requirements financial
"One footnote explains shares were withheld to satisfy tax withholding requirements on vesting of RSUs."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did TNDM executive Elizabeth Gasser report on May 15, 2026?

Elizabeth Gasser reported compensation-related stock activity on May 15, 2026. She exercised restricted stock units into 10,267 common shares, received a 1,337-share grant, and had 5,510 shares withheld by Tandem Diabetes Care Inc. to satisfy tax obligations on vesting.

Did the TNDM Form 4 show any open-market sale of shares by Elizabeth Gasser?

The Form 4 indicates no shares were sold. Footnotes clarify that 5,510 shares were withheld by Tandem Diabetes Care Inc. solely to satisfy tax withholding requirements on restricted stock unit vesting, which is different from selling shares in the open market.

How many Tandem Diabetes Care (TNDM) shares does Elizabeth Gasser hold after these transactions?

After the reported transactions, Elizabeth Gasser directly holds 1,762 shares of Tandem Diabetes Care common stock. She also indirectly holds 25,949 shares through The Gasser Family Trust, where she is identified as a co-trustee, according to the Form 4 footnotes.

What restricted stock unit (RSU) activity for TNDM was disclosed for Elizabeth Gasser?

The filing shows RSU exercises totaling 10,267 underlying common shares at a stated $0.00 price. Footnotes explain these RSUs were granted under Tandem’s 2023 Long-Term Incentive Plan, with vesting schedules that include 33% initial vesting followed by eight equal quarterly installments.

What tax-withholding transactions were reported in the TNDM Form 4 for Elizabeth Gasser?

The Form 4 reports three tax-withholding dispositions totaling 5,510 shares at $12.82 per share. Footnotes state these shares were withheld by Tandem Diabetes Care Inc. to satisfy tax liabilities from RSU vesting, and explicitly note that no shares were sold in the market.

How is the Employee Stock Purchase Plan mentioned in the TNDM Form 4 for Elizabeth Gasser?

A footnote says Gasser voluntarily reported acquiring common stock under Tandem’s Amended and Restated 2013 Employee Stock Purchase Plan for the purchase period from November 18, 2025, through May 15, 2026. The disclosure notes this transaction is exempt under Rule 16b-3(c).
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gasser Elizabeth Anne

(Last)(First)(Middle)
12400 HIGH BLUFF DRIVE

(Street)
SAN DIEGO CALIFORNIA 92130

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TANDEM DIABETES CARE INC [ TNDM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Chief Strategy Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M1,503A$02,569D
Common Stock05/15/2026F(1)807D$12.821,762D
Common Stock05/15/2026M1,097A$02,859D
Common Stock05/15/2026F(1)589D$12.822,270D
Common Stock05/15/2026M7,667A$09,937D
Common Stock05/15/2026F(1)4,114D$12.825,823D
Common Stock05/15/2026A(2)1,337A$10.97,160D
Common Stock25,949ISee Footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(4)(5)05/15/2026M1,503 (6) (6)Common Stock1,503$00D
Restricted Stock Unit(7)(5)05/15/2026M1,097 (8) (8)Common Stock1,097$04,387D
Restricted Stock Unit(9)(5)05/15/2026M7,667 (10) (10)Common Stock7,667$015,335D
Explanation of Responses:
1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
2. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c).
3. The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.
4. Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
5. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
6. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
7. Awarded on May 23, 2024 pursuant to the 2023 Plan.
8. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
9. Awarded on May 30, 2025 pursuant to the 2023 Plan.
10. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Remarks:
/s/ Shannon M. Hansen, Attorney-in-Fact for Elizabeth A. Gasser05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)